The adverse effects of<unk>  are similar to the adverse effects of benzodiazepines, although with less next-day sedation, and in two studies<unk>  use was found not to cause an increase in traffic accidents, as compared to other hypnotics currently on the market. Sleeping pills, including<unk> , have been associated with an increased risk of death. Available data cannot provide a reliable estimate of the incidence of dependence during treatment at recommended doses of<unk>  (typically 5–20 mg before bed). Other sedative/hypnotics have been associated with various signs and symptoms of a withdrawal syndrome, following abrupt discontinuation, ranging from mild dysphoria and insomnia to more serious cases that include abdominal and muscle cramps, vomiting, sweating, tremors, and convulsions. Following abrupt cessation, the seizure threshold is further lowered, wherein coma and death are possible outcomes if untreated. Some evidence suggests<unk>  is not as chemically reinforcing and exhibits far fewer rebound effects when compared with other nonbenzodiazepines, or Z-drugs.
Zaleplon
Bretylium
Toremifene
Tasimelteon
Dezocine
Suvorexant
Icatibant
Fenproporex